Literature DB >> 9007064

Structure-function analysis of coxsackie B3 virus protein 2B.

F J Van kuppeveld1, W J Melchers, K Kirkegaard, J R Doedens.   

Abstract

Expression of poliovirus protein 2B in mammalian cells inhibits protein secretion and increases the susceptibility of the cells to hygromycin B, consistent with the increase in plasma membrane permeability seen during poliovirus infection (J. R. Doedens and K. Kirkegaard, EMBO J. 14, 894-907, 1995). We report here that expression of protein 2B of the closely related coxsackie B3 virus (CBV3) leads to the same biochemical alterations. Analysis of several mutant CBV3 2B proteins that contain mutations in a predicted cationic amphipathic alpha-helix (F. J. M. van Kuppeveld, J. M. D. Galama, J. Zoll, P. J. J. C. van den Hurk, and W. J. G. Melchers, J. Virol. 70, 3876-3886, 1996) demonstrated that the integrity of this domain is crucial for both biochemical functions of 2B. Mutations in a second hydrophobic domain (F. J. M. van Kuppeveld, J. M. D. Galama, J. Zoll, and W. J. G. Melchers, J. Virol. 69, 7782-7790, 1995), on the other hand, are more disruptive to the ability of CBV3 2B to inhibit protein secretion than to increase membrane permeability. Therefore, inhibition of protein secretion is not merely a consequence of the membrane changes that increase uptake of hygromycin B. The existence of mutations that interfere with virus growth but do not impair the ability of 2B to inhibit protein secretion or increase membrane permeability argues for additional functions of protein 2B.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9007064     DOI: 10.1006/viro.1996.8320

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  Poliovirus protein 2BC increases cytosolic free calcium concentrations.

Authors:  R Aldabe; A Irurzun; L Carrasco
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Homomultimerization of the coxsackievirus 2B protein in living cells visualized by fluorescence resonance energy transfer microscopy.

Authors:  Frank J M van Kuppeveld; Willem J G Melchers; Peter H G M Willems; Theodorus W J Gadella
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 3.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  Evolution of poliovirus defective interfering particles expressing Gaussia luciferase.

Authors:  Yutong Song; Aniko V Paul; Eckard Wimmer
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 5.  Ion channels as antivirus targets.

Authors:  Xin Liang; Zhi-Yuan Li
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

6.  Inhibition of protein trafficking by coxsackievirus b3: multiple viral proteins target a single organelle.

Authors:  Christopher T Cornell; William B Kiosses; Stephanie Harkins; J Lindsay Whitton
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Functional analysis of picornavirus 2B proteins: effects on calcium homeostasis and intracellular protein trafficking.

Authors:  Arjan S de Jong; Fabrizio de Mattia; Michiel M Van Dommelen; Kjerstin Lanke; Willem J G Melchers; Peter H G M Willems; Frank J M van Kuppeveld
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

8.  Bypass suppression of small-plaque phenotypes by a mutation in poliovirus 2A that enhances apoptosis.

Authors:  Trever B Burgon; Jomaquai A Jenkins; Stephen B Deitz; Jeannie F Spagnolo; Karla Kirkegaard
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

9.  Identification of regions of poliovirus 2BC protein that are involved in cytotoxicity.

Authors:  A Barco; L Carrasco
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 10.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.